Interaction between marrow-derived human mesenchymal stem cells and peripheral blood mononuclear cells in endothelial cell differentiation

Scandinavian Journal of Surgery

Volumn 100, Issue 3, 2011, Pages 216-222

  Joensuu, K ^a   Paatero, I ^a   Alm, J J ^a   Elenius, K ^a   Aro, H T ^a   Heino, T J ^a   Hentunen, T A ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Angiogenesis; Cell therapy; Endothelialization; Mesenchymal stem cell; Mononuclear cell; Regenerative medicine; Tissue engineering

Indexed keywords

EID: 80054008230     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749691110000314     Document Type: Article

References (33)

1. Pittenger MF, Mackay AM, Beck SC et al: Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147
2. Jiang Y, Jahagirdar B, Reinhard L et al: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49
3. Picinich SC, Mishra PJ, Mishra PJ et al: The therapeutic potential of mesenchymal stem cells. Expert Opin Biol Ther 2007;7:965-973
4. Salem HK, Thiemermann C: Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010;28(3):585-596
5. Wagner J, Kean T, Young T et al: Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol 2009;5:531-536
6. Muschler GF, Nakamoto C, Griffith LG: Engineering principles of clinical cell-based tissue enigeering. J Bone Joint Surg Am 2004;86:1541-1558
7. Giannoudis PV, Einhorn TA, Schmidmaier G et al: The diamond concept-open questions. Injury 2008;2:S5-8
8. Dazzi F, Ramasamy R, Glennie S et al: The role of mesenchymal stem cells in haemopoiesis. Blood Rev 2006;20:161-171
9. Calvi LM, Adams GB, Weibrecht KW: Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425:841-846
10. Wang M, Crisostomo P, Herring C et al: Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF and IGF-1 in response to TNF by a p38 mitogen activated protein kinase dependent mechanism. Am J Physiol Regul Integr Comp Physiol 2006;291:880-884
11. Martens TP, See F, Schuster MD et al: Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nat Clin Pract Cardiovasc Med 2006;3:S18-S22.
12. Mathiasen AB, Haack-Sørensen M, Kastrup J: Mesenchymal stromal cells for cardiovascular repair: current status and future challenges. Future Cardiol 2009;6:605-617
13. Cselenyak A, Pankotai E, Hovath EM et al: Mesenchymal stem cells rescue cardiomyoblasts from cell death in an ischemia model via direct cell-to-cell connections. BMC Cell Biology 2010;11:29
14. Asahara T, Murohara T, Sullivan A et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-966
15. Shi Q, Rafii S, Wu MH et al: Evidence for circulating bone marrow-derived endothelial cells. Blood 1998;92:362-367
16. Boyer M, Townsend LE, Vogel LM et al: Isolation of endothelial cells and their progenitor cells from human peripheral blood. J Vasc Surg 2000;31:181-189
17. Zhang R, Yang H, Li M et al: Acceleration of endothelial-like cell differentiation from CD14+ monocytes in vitro. Exp Hematol 2005;33:1554-1563
18. Asahara T, Masuda H, Takahashi T et al: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-228
19. Takahashi T, Kalka C, Masuda H et al: Ischemia-and cytokineinduced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438.
20. Güven H, Shepherd RM, Bach RG et al: The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 2006;48:1579-1587
21. Lin Y, Weisdorf DJ, Solovey A et al: Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-77
22. Walenta K, Friedrich EB, Sehnert F et al: In vitro differentiation characteristics of cultured human mononuclear cells-implications for endothelial progenitor cell biology. Biochem Biophys Res Commun 2005;333:476-482
23. Junttila TT, Laato M, Vahlberg T et al: Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. Clin Cancer Res 2003;9:5346-5357
24. Hayman AR, Bune AJ, Cox TM: Widespread expression of tartrate-resistant acid phosphatase (Acp 5) in the mouse embryo. J Anat 2000;196:433-441
25. Albelda SM, Muller WA, Buck CA et al: Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule. J Cell Biol 1991;114:1059-1068
26. Mercado-Pimentel ME, Hubbard AD, Runyan RB: Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation. Develop Biol 2007;304:420-432
27. Ferrara N, Gerber H-P, LeCouter J: The biology of VEGF and its receptors. Nat Med 2003;9:669-676
28. Silva GV, Litovsky S, Assad JA et al: Mesenchymal stem cells differentiate into a endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005;111:150-156
29. Davani S, Marandin A, Mersin N et al: Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model, Circulation 2003;108:253-258
30. Oddie GW, Schenk G, Angel NZ et al: Structure, function and regulation of tartrate-resistant acid phosphatase. Bone 2000;27:575-584
31. Perez-Amodio S, Vogels IMC, Schoenmaker T et al: Endogenous expression and endocytosis of tartrate-resistant acid phosphates by osteoblast-like cells. Bone 2005;36:1065-1077
32. Husheem M, Nyman JKE, Vääräniemi J et al: Characterization of Circulating Human Osteoclast Progenitors: Development of In Vitro Resorption Assay. Calcif Tissue Int 2005;76:222-230
33. Atsma DE, Fibbe WE, Rabelink TJ: Opportunities and challenges for mesenchymal stem cell-mediated heart repair. Curr Opin Lipidol 2007;18:645-649